Hang, QuachDimopoulos, MeletiosBeksac, MeralPour, LudekDelimpasi, SosanaVorobyev, Vladimir2025-06-032025-06-032024Quach, H., Dimopoulos, M., Beksac, M., Pour, L., Delimpasi, S., Vorobyev, V., ... & Trudel, S. (2024). Characterization and Management of Ocular Events in Patients Treated with Belantamab Mafodotin Plus Pomalidomide and Dexamethasone in the DREAMM-8 Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 24, S273-S273.2152-26502152-2669https://hdl.handle.net/20.500.12713/7287Characterization and management of ocular events in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone in the DREAMM-8 studyeninfo:eu-repo/semantics/closedAccessCharacterization and management of ocular events in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone in the DREAMM-8 studyOther24273273WOS:001325737900475Q2